HoyleCohen’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-36,752
Closed -$3.65M 200
2019
Q3
$3.65M Sell
36,752
-200
-0.5% -$19K 0.62% 48
2019
Q2
$3.42M Sell
36,952
-75
-0.2% -$7.12K 0.59% 49
2019
Q1
$3.49M Sell
37,027
-325
-0.9% -$28.4K 0.62% 49
2018
Q4
$2.39M Sell
37,352
-1,720
-4% -$127K 0.49% 56
2018
Q3
$3.5M Buy
39,072
+35
+0.1% +$3.09K 0.66% 44
2018
Q2
$3.1M Sell
39,037
-275
-0.7% -$22.8K 0.63% 47
2018
Q1
$3.51M Buy
39,312
+1,855
+5% +$178K 0.71% 44
2017
Q4
$3.91M Buy
+37,457
New +$4.23M 0.77% 42

Other funds holding CELG

HoyleCohen's CELG Position: Q4 2019 in Review

HoyleCohen sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 36,752 shares — an estimated $3.65M sold.

HoyleCohen first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $3.91M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HoyleCohen reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HoyleCohen sold 36,752 Celgene Corp shares in Q4 2019, an estimated $3.65M.
  • HoyleCohen first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • HoyleCohen's Celgene Corp position peaked at $3.91M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HoyleCohen's 13F filing for Q4 2019, filed 10 Feb 2020.